Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Bone marrow derived allogenic mesenchymal stem cells - ImmunityBio

Next Previous
Drug Profile

Bone marrow derived allogenic mesenchymal stem cells - ImmunityBio

Alternative Names: BM-Allo-MSC; BM-Allo.MSC

Latest Information Update: 19 Sep 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator ImmunityBio
  • Class Mesenchymal stem cell therapies; Stem cell therapies
  • Mechanism of Action Cell replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I SARS-CoV-2 acute respiratory disease

Most Recent Events

  • 19 Sep 2024 BM-Allo-MSC is still in phase I trial for SARS-COV-2 acute respiratory disease (In adults, In the elderly) in USA (Parenteral) (NCT04397796)
  • 05 Sep 2024 ImmunityBio terminates a phase I trial for SARS-COV-2 acute respiratory disease (In adults, In the elderly) in USA (Parenteral), as study halted prematurely and will not resume (NCT04397796)
  • 09 Mar 2021 NantKwest has been merged with ImmunityBio to form ImmunityBio

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top